President-elect Trump has recently made some key appointments in the health sector, including the FDA commissioner, CDC director, and surgeon general. These individuals have stirred up some controversy due to their backgrounds and previous statements.
Marty Makary, Trump’s pick for FDA commissioner, is a well-known surgeon from Johns Hopkins who has been critical of certain aspects of the U.S. medical system. He has also defended RFK Jr.’s views in the past. Trump has tasked him with addressing harmful chemicals and pharmaceuticals to combat childhood chronic illnesses.
Dave Welton, the planned nominee for CDC director, is a former Florida congressman and physician who has raised concerns about vaccine safety and advocated against abortion access. Trump has assigned him the responsibility of reforming the CDC, a task he has supported over the years.
Janette Nesheiwat, a medical doctor and former Fox News contributor, is set to be nominated as the next surgeon general. Unlike some of her counterparts, Nesheiwat does not have a history of criticizing vaccines. She currently serves as a medical director at CityMD, an urgent care network.
Makary’s appointment as FDA commissioner has raised eyebrows, as he has previously been vocal in his criticisms of the agency. During the COVID-19 pandemic, he accused the FDA of being too slow in authorizing vaccines and treatments, leading to some tension between him and the agency.
These appointments signal a shift in the leadership of key health organizations, with individuals who have strong opinions and backgrounds in controversial issues. It remains to be seen how they will navigate their new roles and address the challenges facing the health sector in the coming years.
